A catalytic membrane approach as a way to obtain sweet and unsweet lactose-free milk.

Open access · hybridAbstract read

In one paragraph

Article in Bioprocess and biosystems engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact, top 94% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Katarzyna CzyżewskaFaculty of Chemistry, Group of Micro, Nano, and Bioprocess Engineering, Wroclaw University of Science and Technology, Norwida 4/6, 50-373, Wrocław, Poland. katarzyna.czyzewska@pwr.edu.pl.ORCID http://orcid.org/0000-0001-5639-2152

Anna TrusekFaculty of Chemistry, Group of Micro, Nano, and Bioprocess Engineering, Wroclaw University of Science and Technology, Norwida 4/6, 50-373, Wrocław, Poland.ORCID http://orcid.org/0000-0002-3886-7166

Wrocław University of Science and Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growing need in the current market for innovative solutions to obtain lactose-free (L-F) milk is caused by the annual increase in the prevalence of lactose intolerance inside as well as the newborn, children, and adults. Various configurations of enzymes can yield two distinct L-F products: sweet (β-galactosidase) and unsweet (β-galactosidase and glucose oxidase) L-F milk. In addition, the reduction of sweetness through glucose decomposition should be performed in a one-pot mode with catalase to eliminate product inhibition caused by H

Indexed as

beta-GalactosidaseEnzymes, ImmobilizedGlucose OxidaseLactoseMilkAnimalsAspergillus nigerCatalaseGlucoseMembranes, Artificialbeta-GalactosidaseCatalaseEnzymes, ImmobilizedGlucoseGlucose OxidaseLactoseMembranes, ArtificialCatalaseCo-immobilizationGlucose oxidaseNOLA Fit 5500

Identifiers

PMID38644439

DOI10.1007/s00449-024-03018-z

PMCPMC11101535

OpenAlexW4395007664

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.